Capricor Therapeutics | CAPR - Current Assets


Capricor Therapeutics reported $242.13M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Bioline Rx USD 21.58M 2.1M Mar/2026
Capricor Therapeutics USD 242.13M 40.96M Jun/2026
Cipla INR 241.47B 7.71B Mar/2026
Cytokinetics USD 1.21B 369.02M Jun/2026
Geron USD 486.34M 12.19M Jun/2026
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 188.76M 165.89M Mar/2026
J&J USD 59.77B 601M Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Prothena USD 292.01M 47.19M Jun/2026
PTC Therapeutics USD 2.62B 363.36M Jun/2026
Sarepta Therapeutics USD 2.22B 86.05M Jun/2026